◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › L › LIVN

LivaNova PLC (LIVN) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-08-22

LivaNova PLC (LIVN) operates in the MEDICAL DEVICES industry and is headquartered in Gloucester, United Kingdom with about 3,300 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-12-31, LIVN reported $1.4B in revenue and ($242M) in net income.

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation.

Interactive charts & full statements → Open the LIVN valuation workbench →

LIVN Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$1.5B	$1.4B	$1.3B	$1.2B	$1.0B	$1.0B	$934M	$1.1B	$1.1B	$1.0B	$1.2B	$292M	$282M	$282M	$254M	$219M	$190M	$168M	$144M	$121M	$131M
Gross Profit	$1.0B	$940M	$871M	$771M	$707M	$706M	$595M	$724M	$734M	$652M	$704M	$264M	$255M	$255M	$232M	$199M	$167M	$147M	$124M	$100M	$113M
Gross Margin %	68.2%	67.7%	69.5%	66.9%	69.2%	68.2%	63.7%	66.8%	66.3%	64.4%	58.0%	90.6%	90.3%	90.3%	91.4%	91.0%	87.9%	87.5%	86.0%	82.6%	86.1%
Operating Income (EBIT)	$198M	$199M	$129M	($68M)	($77M)	($1M)	($274M)	($172M)	($248M)	$96M	($28M)	$89M	$80M	$80M	$78M	$61M	$49M	$37M	$19M	($8M)	($50M)
Operating Margin %	13.5%	14.4%	10.3%	-5.9%	-7.5%	-0.1%	-29.3%	-15.8%	-22.4%	9.4%	-2.3%	30.4%	28.4%	28.4%	30.8%	27.9%	25.8%	22.0%	13.2%	-6.8%	-37.8%
Net Income	$189M	($242M)	$63M	$18M	($86M)	($136M)	($349M)	($158M)	($189M)	($25M)	($63M)	$58M	$55M	$55M	$46M	$36M	$47M	$78M	$27M	($10M)	($51M)
Net Margin %	12.8%	-17.5%	5.0%	1.5%	-8.4%	-13.1%	-37.3%	-14.5%	-17.1%	-2.5%	-5.2%	19.8%	19.5%	19.5%	18.2%	16.5%	24.5%	46.8%	18.6%	-8.5%	-39.1%
EBITDA	$181M	($130M)	$203M	$38M	$31M	($6M)	$6M	$119M	($168M)	$199M	$99M	($26M)	$93M	$93M	$93M	$83M	$66M	$52M	$22M	$33M	($2M)
Earnings Per Share (EPS)	$3.38	$-4.45	$1.16	$0.32	$-1.61	$-2.68	$-7.18	$-3.26	$-3.91	$-0.52	$-1.28	$2.17	$2.00	$2.00	$1.66	$1.27	$1.63	$2.73	$0.97	$-0.39	$-2.01
Shares Outstanding (M)	56M	54M	55M	54M	54M	51M	49M	48M	48M	48M	49M	27M	27M	27M	28M	28M	29M	29M	28M	26M	26M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LIVN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$391M	$362M	$361M	$358M	$353M	$317M	$322M	$318M
Gross Profit	$274M	$245M	$240M	$245M	$239M	$221M	$219M	$225M
Gross Margin %	70.1%	67.6%	66.5%	68.5%	67.8%	69.7%	68.2%	70.8%
Operating Income (EBIT)	$50M	$52M	$43M	$54M	$54M	$49M	$37M	$36M
Operating Margin %	12.7%	14.4%	11.8%	15.1%	15.4%	15.3%	11.5%	11.2%
Net Income	$109M	$22M	$31M	$27M	$27M	($327M)	$56M	$33M
Net Margin %	27.8%	6.2%	8.6%	7.5%	7.7%	-103.3%	17.4%	10.4%
EBITDA	$26M	$51M	$47M	$57M	$61M	($286M)	$85M	$73M
Earnings Per Share (EPS)	$1.93	$0.40	$0.57	$0.49	$0.50	$-6.01	$1.02	$0.60
Shares Outstanding (M)	56M	56M	54M	55M	55M	54M	55M	55M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LIVN Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$249M	$254M	$183M	$75M	$70M	$103M	($79M)	($91M)	$120M	$91M	$90M	$80M	$54M	$54M	$79M	$75M	$50M	$43M	$25M	$14M	($21M)
Capital Expenditures (CapEx)	$101M	$81M	$47M	$35M	$26M	$25M	$35M	$25M	$38M	$34M	$37M	$7M	$19M	$19M	$14M	$18M	$7M	$6M	$3M	$1M	$1M
Free Cash Flow (FCF)	$148M	$173M	$136M	$40M	$43M	$77M	($114M)	($116M)	$82M	$57M	$53M	$73M	$35M	$35M	$65M	$57M	$42M	$37M	$22M	$14M	($22M)
FCF Margin %	10.1%	12.5%	10.8%	3.5%	4.2%	7.4%	-12.2%	-10.7%	7.4%	5.7%	4.4%	25.0%	12.5%	12.5%	25.5%	26.1%	22.3%	21.9%	15.3%	11.2%	-16.9%
Dividends Paid	—	—	—	—	—	—	—	$5M	—	$0M	$0M	—	—	—	—	—	—	$43M	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LIVN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$67M	$15M	$82M	$85M	$63M	$24M	$79M	$51M
Capital Expenditures (CapEx)	$32M	$14M	$32M	$23M	$15M	$11M	$10M	$18M
Free Cash Flow (FCF)	$35M	$1M	$50M	$62M	$48M	$13M	$68M	$33M
FCF Margin %	9.0%	0.3%	13.9%	17.4%	13.6%	4.2%	21.2%	10.3%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LIVN Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$2.6B	$2.6B	$2.5B	$2.4B	$2.3B	$2.2B	$2.4B	$2.4B	$2.5B	$2.5B	$2.3B	$2.6B	$294M	$294M	$264M	$212M	$211M	$207M	$146M	$105M	$136M
Cash & Cash Equivalents	$517M	$636M	$429M	$267M	$214M	$208M	$253M	$61M	$47M	$94M	$40M	$113M	$103M	$103M	$121M	$97M	$89M	$85M	$55M	$63M	$90M
Total Liabilities	$1.3B	$1.4B	$1.2B	$1.2B	$1.1B	$906M	$1.3B	$1.0B	$1.0B	$689M	$636M	$747M	$35M	$35M	$34M	$28M	$36M	$34M	$47M	$90M	$151M
Total Debt (Short + Long-Term)	$302M	$377M	$637M	$595M	$551M	$251M	$667M	$349M	$168M	$146M	$123M	$174M	$270M	$270M	$0M	$0M	$0M	$23M	$62M	$125M	$125M
Total Shareholders' Equity	$1.3B	$1.2B	$1.3B	$1.3B	$1.2B	$1.3B	$1.1B	$1.4B	$1.5B	$1.8B	$1.7B	$1.8B	$259M	$259M	$230M	$183M	$175M	$173M	$99M	$16M	($15M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LIVN viewer.

Other Companies in MEDICAL DEVICES

GKOS · Glaukos Corp — $10 billion
BRKR · Bruker Corporation — $9 billion
HAE · Haemonetics Corporation — $5 billion
ITGR · Integer Holdings Corp — $4 billion
IRTC · iRhythm Technologies Inc — $4 billion
TMDX · TransMedics Group Inc — $3 billion
NEOG · Neogen Corporation — $3 billion
AXGN · Axogen Inc — $3 billion

← LIVE All “L” companies LJAN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.